Langkau ke kandungan utama

Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria

Juga terdapat dalam

Cerebral malaria can lead to coma and death, even when the patient is given anti-malarial drugs. Death is caused by the malaria parasites in the brain that cause brain swelling, leading to pressure in the brain. Mannitol is a drug that sometimes reduces brain swelling in other situations, such as traumatic head injury.

We searched for studies testing mannitol given in addition to anti-malarial drugs in children with cerebral malaria. One study, carried out in Uganda, was found. A total of 156 children were randomly divided to receive either mannitol or placebo (saline solution) in addition to quinine, which is an anti-malarial drug. No difference in either the numbers of deaths, or the time to recover from coma was found in this study. More studies are needed, but from this review mannitol cannot be currently recommended for use in cerebral malaria.

Latar Belakang

Cerebral oedema occurs with cerebral malaria, and some clinicians think osmotic diuretics, such as mannitol or urea, may improve outcomes.

Matlamat

To compare mannitol or urea to placebo or no diuretic for treating children or adults with cerebral malaria.

Kaedah Pencarian

We searched the Cochrane Infectious Diseases Group Specialized Register (Issue 4, 2010), CENTRAL (The Cochrane Library Issue 12, 2010), MEDLINE (1966 to November 2010), EMBASE (1974 to November 2010), LILACS (1982 to November 2010), and the reference lists of articles. We contacted relevant organizations and researchers.

Kriteria Pemilihan

Randomized or quasi-randomized controlled trials comparing mannitol or urea to placebo or no treatment in children and adults with cerebral malaria. Primary outcomes were death, life-threatenining sequelae and major neurological sequelae at six months.

Pengumpulan Data dan Analisis

Two authors applied the inclusion criteria, assessed risk of bias, and extracted data independently.

Keputusan Utama

One trial met the inclusion criteria, comparing mannitol 20% to saline placebo in 156 Ugandan children. Allocation was concealed. No difference in mortality, time to regain consciousness, or neurological sequelae were detected.

Kesimpulan Pengarang

There are insufficient data to know what the effects of osmotic diuretics are in children with cerebral malaria. Larger, multicentre trials are needed.

Petikan
Okoromah CAN, Afolabi BB, Wall ECB. Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria. Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD004615. DOI: 10.1002/14651858.CD004615.pub3.

Penggunaan cookie kami

Kami menggunakan cookie yang diperlukan untuk menjadikan laman web kami berfungsi. Kami juga ingin menetapkan cookie analitik pilihan untuk membantu kami memperbaikinya. Kami tidak akan menetapkan cookie pilihan melainkan anda mengaktifkannya. Menggunakan alat ini akan menetapkan cookie pada peranti anda untuk mengingati pilihan anda. Anda boleh menukar pilihan cookie anda pada bila-bila masa dengan menekan pautan 'Tetapan cookie' di bahagian bawah setiap halaman.
Untuk maklumat lebih terperinci mengenai cookie yang kami gunakan, lihat halaman halaman cookie.

Terima semua
Konfigurasikan